Results
1 -
10 of
17
(Click
here to explore results)
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- Foreign Compound Metabolism in Mammals: Volume 5, Effect of drugs on the central nervous system. D. E. Hathway, B. E. Leonard
, 1979
, Volume 5
, Pages 244-319
- Drug Discovery for Psychiatric Disorders, CHAPTER 6 Treating the Cognitive Deficits of Schizophrenia. Bruce N. Rogers, David L. Gray
, 2012
, Pages 123-156
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 6 D3 Receptor Agonists and Antagonists as Anti‐Parkinsonian Therapeutic Agents. Mark Johnson, Aloke Dutta
, 2013
, Pages 126-148
- Comprehensive Glossary of Terms Used in Toxicology, APPENDIX I A Selection of Toxic Substances
, 2017
, Pages 712-746
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 13 5‐HT1A Receptors as a Therapeutic Target for Parkinson’s Disease. Saki Shimizu, Yukihiro Ohno
, 2013
, Pages 308-326
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 14 Ergot Alkaloids. Dorota Jakubczyk, Sarah O'Connor
, 2016
, Pages 379-397
- Chemistry, Biological Activities and Therapeutic Applications of Medicinal Plants in Ayurveda, Chapter 6 Scientific Evaluation of the Role of Ocimum sanctum in Ayurvedic Formulations and Its Phytochemistry and Pharmacological Activities. Haamid Rasheed, Suhail Ahmed, Harjeet Singh, Alok Sharma
, 2023
, Pages 108-147
- Emerging Drugs and Targets for Parkinson's Disease, Subject Index
, 2013
, Pages 390-402
- Pharmaceuticals in the Environment, Distribution of Pharmaceutical Residues in the Environment. Benoit Roig, Vince D’Aco
, 2016
, Pages 34-69